GW Vitek CO.,LTD. (KOSDAQ:036180)

Market Cap	53.93B
Revenue (ttm)	28.07B
Net Income (ttm)	-12.25B
Shares Out	93.46M
EPS (ttm)	-140.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	577.00
Previous Close	577.00
Day's Range	577.00 - 577.00
52-Week Range	429.00 - 643.00
Beta	0.81
RSI	74.66
Earnings Date	May 14, 2025

About GW Vitek CO.,LTD.

GW Vitek CO.,LTD., together with its subsidiaries, engages in the development, manufacturing, and sale of bio-related antibodies and biotechnology solutions in Korea, the United States, Asia, Europe, and internationally. It is also involved in supply of scientific equipment and related consumables; and provision of technology services. The company was formerly known as A-Frontier Co.,Ltd. and changed its name to GW Vitek CO.,LTD. in December 2020. GW Vitek CO.,LTD. was founded in 1994 and is headquartered in Seoul, South Korea.

• Industry: Radio and Television Broadcasting and Communications Equipment
• Founded: 1994
• Employees: 94
• Stock Exchange: KOSDAQ
• Ticker Symbol: 036180

Financial Performance

In 2024, GW Vitek CO.,LTD.'s revenue was 28.07 billion, a decrease of -41.42% compared to the previous year's 47.92 billion. Losses were -12.25 billion, -17.94% less than in 2023.